Globalization of P4 medicine: Predictive, personalized, preemptive, and participatory - Summary of the Proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology, August 27-29, 2009 Journal Article
| Authors: | Bradley, W. G.; Golding, S. G.; Herold, C. J.; Hricak, H.; Krestin, G. P.; Lewin, J. S.; Miller, J. C.; Ringertz, H. G.; Thrall, J. H. |
| Article Title: | Globalization of P4 medicine: Predictive, personalized, preemptive, and participatory - Summary of the Proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology, August 27-29, 2009 |
| Abstract: | In August 2009, the International Society for Strategic Studies in Radiology held its eighth biennial meeting. The program focused on the globalization of predictive medicine - or P4 medicine - as it relates to the practice of radiology and radiology research. P4 medicine refers to predictive, personalized, preemptive, and participatory medicine and was the inspiration of Elias Zerhouni, MD, former director of the National Institutes of Health. This article is a summary of some of the key concepts presented at the meeting by an international group of radiologists, imaging scientists, and leaders of industry. In predictive medicine, imaging and imaging-related technologies will likely play an increasing role in the early detection of disease and, thus, the preemption of the development of advanced, hard-to-treat disease. Research into systems biology and molecular imaging promises to personalize medicine, facilitating the provision of the right care to the right patient at the right time. In participatory medicine, increasing interactions with referring physicians and patients will be helpful in raising awareness and recognition of the role of radiologists and will have a positive effect on professionalism. There is also a need to increase awareness of the vital role of radiologists as imaging and radiation safety experts who evaluate the necessity and appropriateness of examinations, monitor performance quality, and are available for postexamination consultations. © RSNA, 2011. |
| Keywords: | nuclear magnetic resonance imaging; diagnostic accuracy; sensitivity and specificity; clinical practice; biological marker; biomedical research; breast cancer; image analysis; cancer screening; lung cancer; molecular imaging; diagnostic imaging; mutational analysis; cetuximab; health care quality; cost effectiveness analysis; health care cost; patient care; doctor patient relation; professional practice; radiologist; radiology; mammography; early diagnosis; cardiovascular disease; colon cancer; medical research; drug response; computer assisted emission tomography; gefitinib; physician-patient relations; medical society; forecasting; consultation; radiation safety; k ras protein; physician's role; medicine; health care delivery; internationality; degenerative disease; computed tomographic angiography; systems biology; multidetector computed tomography; personalized medicine; preventive medicine; individualized medicine; commercial phenomena; globalization; job performance; participatory medicine; preemptive medicine |
| Journal Title: | Radiology |
| Volume: | 258 |
| Issue: | 2 |
| ISSN: | 0033-8419 |
| Publisher: | Radiological Society of North America, Inc. |
| Date Published: | 2011-02-01 |
| Start Page: | 571 |
| End Page: | 582 |
| Language: | English |
| DOI: | 10.1148/radiol.10100568 |
| PUBMED: | 21273521 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 23 June 2011" - "CODEN: RADLA" - "Source: Scopus" |
